Beranda › Penyakit Paru Interstisial › Illinois › Chicago
Uji klinis Penyakit Paru Interstisial di Chicago, IL
12 studi untuk Penyakit Paru Interstisial mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Pulmonary Fibrosis Foundation Community Registry
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Pulmonary Fibrosis Foundation, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Menerima pesertaFase 2/3
- GSK Investigational Site, Chicago
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Menerima peserta
- Northwestern University, Chicago
- University of Illinois Health, Chicago
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Menerima pesertaFase 3
- Northwestern University, Chicago
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Menerima pesertaFase 2
- Clinical Research Site, Chicago
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaStudi observasional
- Northwestern University, Chicago
Platform Clinical Study for Conquering Scleroderma
Menerima pesertaFase 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Menerima pesertaFase 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Menerima pesertaStudi observasional
- University of Chicago, Chicago
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Menerima pesertaFase 3
- Northwestern Memorial Hospital, Clinical Research Unit, Chicago
- Rush University Medical Center Outpatient Pulmonary Clinic, Chicago
- UI Health Hospital, Chicago
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- University of Chicago, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Menerima pesertaFase 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Uji klinis Penyakit Paru Interstisial di kota lain
- New York City, NY18 studi
- Philadelphia, PA16 studi
- Los Angeles, CA14 studi
- Kansas City, KS13 studi
- Durham, NC13 studi
- Charleston, SC13 studi
- Houston, TX12 studi
- Ann Arbor, MI11 studi
- Aurora, CO11 studi
- Phoenix, AZ9 studi
- Salt Lake City, UT9 studi
- Boston, MA9 studi
Studi lain di Chicago
- Kanker Paru Non-Sel Kecil61 studi
- Kanker Payudara58 studi
- Kanker (semua jenis)51 studi
- Kanker Metastatik45 studi
- Kanker Prostat45 studi
- Obesitas41 studi
- Kanker Paru41 studi
- Kanker Ovarium36 studi
- Stroke34 studi
- Kanker Kolorektal33 studi
- Gagal Jantung31 studi
- Kelebihan Berat Badan28 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.